Location: Home
  • search
  • go
  • Relate News
  • 1/6/2025I-Mab Reprioritizes Pipeline and Halts CD73 Development
  • 1/6/2025Solasia Pharma Partners with GenSci to Boost Sales of Episil in China
  • 1/6/2025NHC Issues Guidelines for Clinical Use of New Anticancer Drugs (2024 E...
  • 1/3/2025Brii Biosciences Acquires BRII-179 Assets from VBI Vaccines
  • 1/3/2025Biocon Wins NMPA Approval for Tacrolimus Capsules in China
  • 1/3/2025China Punishes 40,000 in Medical Corruption Crackdown, Targeting Over ...
  • 1/3/2025China Launches Mini-Programs to Boost Drug Price Transparency
  • 1/3/2025New Horizon Health Faces Deeper Crisis as Chairman and CEO Step Down
  • 1/3/2025China Strengthens Oversight of Medical Insurance Funds with Traceabili...
  • 1/3/2025China Prioritizes Mental Health with Nationwide Initiative
  • 1/3/2025WuXi Biologics and Sino Biopharm Partner on mAb Discovery
  • 1/3/2025NMPA Withdraws Registration for Belladonna Sulfabenzamide Tablets
  • 1/3/2025NMPA Issues Annexes for Pharmaceutical Excipients and Packaging Materi...
  • 1/3/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (90...
  • 1/3/2025CDE Issues the Technical Guidelines for Clinical Pharmacology Research...
  • 1/3/2025HighLightHill Pharma Secures CNY 150M in Series Pre-C Financing
  • 1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
  • 1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...
  • 1/3/2025Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
  • 1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing
  • 1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...
  • 1/3/2025Recent Official and Executive Moves
  • 1/2/2025Roche and Innovent Enter Global License Deal for Novel DLL3 ADC 
  • 1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale
  • 12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...
  • 12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...
  • 12/30/2024Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...
  • 12/30/2024NMPA Announces Package Insert Revision of Potassium Bismuth Citrate Gr...
  • 12/30/20242025 New Drug Outlook: Increasing Global Launch Share of Chinese Innov...
  • 12/30/2024NMPA Approves Alpha/AZ's Zorifer for NSCLC
  • Page:46/790 Total number of articles:23674: [First][<<] [44] [45] [46] [47] [48] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group